Five Questions

  • Q&A with Team USA physician

    A native of South Korea, the sports medicine specialist will be traveling to his home country for the Winter Olympics, where he’ll be on call to treat American athletes.

  • Mello on clinical trial reporting

    A Stanford professor of law and of health policy discusses the ranking of large pharmaceutical companies based on their sharing of clinical trial information with the public.

  • Stafford on high blood pressure

    Under the new guidelines, tens of millions more Americans now meet the criteria for having high blood pressure.

  • New guidelines for PANS/PANDAS

    Stanford clinicians helped develop the first clinical guidelines for treating pediatric acute-onset neuropsychiatric syndrome, a psychiatric problem linked to brain inflammation.

  • Stefanick on better medicine for women

    A Stanford professor of medicine discusses why giving consideration to sex and gender differences in research and treatment would improve medical care for everyone.

  • Kelly Ormond on germline editing

    A Stanford professor of genetics discusses the thinking behind a formal policy statement endorsing the idea that researchers continue editing genes in human germ cells.

  • Samuel So on ending viral hepatitis

    A Stanford liver disease expert and leading anti-hepatitis campaigner recently discussed what it will take to rub out viral hepatitis and why it’s important. Hint: It causes more than 20,000 U.S. deaths annually.

  • Almond discusses trial of kids’ heart pump

    Stanford is leading a multisite study of a new ventricular assist device for children who are awaiting heart transplantation. The miniature pump is slightly bigger than a paper clip.

  • Adelsheim on CDC’s youth suicide report

    The recent federal report on suicides among youth in Santa Clara County will inform how the community continues to support mental health for young people, said Stanford psychiatrist Steven Adelsheim.

  • Clues to why severe dengue affects some

    A new study has found a specific immunologic response among people likely to get severe dengue disease. The work could help lead to a screening test for people at risk of getting a serious case of the disease and to targeted vaccines.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.